Your session is about to expire
← Back to Search
Exercise for Alcoholism (ALIVE-Ex Trial)
N/A
Waitlist Available
Led By Patricia Molina, MD, PhD
Research Sponsored by Louisiana State University Health Sciences Center in New Orleans
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
ALIVE-Ex Trial Summary
This trial will study whether people with HIV who drink alcohol are more likely to have problems with their blood sugar levels and whether an exercise intervention can help improve glycemic control.
Eligible Conditions
- Alcoholism
- HIV/AIDS
- Hyperglycemia or Hypoglycemia
ALIVE-Ex Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline in fasting plasma glucose after 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline in fasting plasma glucose after 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fasting plasma glucose and OGTT values (subclinical dysglycemia)
Secondary outcome measures
Fasting plasma glucose
Skeletal muscle phenotype
myomiRs
ALIVE-Ex Trial Design
1Treatment groups
Experimental Treatment
Group I: ExerciseExperimental Treatment1 Intervention
Aerobic exercise program using treadmill.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
Find a Location
Who is running the clinical trial?
Louisiana State University Health Sciences Center in New OrleansLead Sponsor
115 Previous Clinical Trials
43,995 Total Patients Enrolled
1 Trials studying Alcoholism
40 Patients Enrolled for Alcoholism
Patricia Molina, MD, PhDPrincipal Investigator - Louisiana State University Health Sciences Center
Louisiana State University Health Sciences Center in New Orleans
1 Previous Clinical Trials
232 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are allergic to lidocaine, which is used during muscle biopsies.You have severe nerve damage in your arms or legs that affects your ability to exercise.If you have heart problems, especially when exercising, you may not be able to participate.You do not have a diagnosis of diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger